ESTUTC-5 New YorkLog in Sign up

ACRS
Aclaris Therapeutics, Inc.
stockNASDAQ

At CloseNov 13, 2026 3:59:59 PM EST

3.92USD-2.000%(-0.08)1,146,560

After-hoursNov 13, 2026 4:00:30 PM EST

3.92USD0.000%(-0.00)

ACRS News

Day breaks

07:30 AM ESTAclaris Therapeutics to Participate in the Jefferies Global Healthcare Conference ·

GlobeNewswire Inc.

07:22 AM ESTAclaris Therapeutics GAAP EPS of -$0.12 beats by $0.04, revenue of $1.48M beats by $0.25M ·

Seeking Alpha

12:39 PM EDTAclaris Therapeutics, Inc. (ACRS) Discusses ATI-052 Proof-of-Concept Results in Atopic Dermatitis and Asthma Transcript ·

Seeking Alpha

06:43 AM EDTAclaris Therapeutics Announces Pricing of $50.0 Million Offering of Common Stock and Pre-Funded Warrants ·

GlobeNewswire Inc.

06:00 AM EDTAclaris Therapeutics Announces Positive Phase 1b Proof-of-Concept Primary Analysis Results for its Anti-TSLP/IL-4Rα Bispecific ATI-052 in Atopic Dermatitis (AD) and Asthma ·

GlobeNewswire Inc.

08:00 AM EDTCantor Fitzgerald reiterates Aclaris Therapeutics stock rating ·

Investing.com

08:40 AM EDTCantor Fitzgerald reiterates Aclaris Therapeutics stock rating ·

Investing.com